CSGP vs DMAC · P/E 484, rev $2.74B vs $157.4M cap
CoStar Group Inc (CSGP) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
DMAC does not have a complete income-statement cache yet.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CSGP and DMAC stock pages for the full models.
Not investment advice.